Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Aphrodisiacs
Chemical Hazard Release
Compliance with pharmacologic therapy for osteoporosis.
M?llerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection.
Paralyses, Familial Periodic
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Compliance with pharmacologic therapy for osteoporosis.
Yood RA, Emani S, Reed JI, Lewis BE, Charpentier M, Lydick E. Compliance with pharmacologic therapy for osteoporosis. Osteoporos Int. 2003 Dec; 14(12):965-8.
View in:
PubMed
subject areas
Aged
Alendronate
Bone Density
Bone Density Conservation Agents
Calcitonin
Estrogens
Etidronic Acid
Female
Hip
Humans
Lumbar Vertebrae
Middle Aged
Osteoporosis, Postmenopausal
Patient Compliance
Treatment Outcome